U.S. Markets open in 3 hrs 56 mins

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
9.90-0.35 (-3.41%)
At close: 4:00PM EDT
People also watch
SGENALNYZIOPIMGNPGNX
Full screen
Previous Close10.25
Open10.25
Bid6.50 x 100
Ask11.30 x 500
Day's Range9.80 - 10.45
52 Week Range2.65 - 12.05
Volume1,674,911
Avg. Volume1,320,553
Market Cap826.06M
Beta3.89
PE Ratio (TTM)-9.75
EPS (TTM)-1.01
Earnings DateOct 24, 2017 - Oct 30, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.60
Trade prices are not sourced from all markets
  • This Stock Could Be the Tesla of Healthcare
    Motley Fool16 hours ago

    This Stock Could Be the Tesla of Healthcare

    A little-known gene-editing pioneer, Editas Medicine, could have what it takes.

  • These Stocks Have Tripled This Year
    Motley Fool2 days ago

    These Stocks Have Tripled This Year

    Can these red-hot companies keep climbing?

  • Sangamo Therapeutics, Inc. – Value Analysis (NASDAQ:SGMO) : August 17, 2017
    Capital Cube4 days ago

    Sangamo Therapeutics, Inc. – Value Analysis (NASDAQ:SGMO) : August 17, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Sangamo Therapeutics, Inc. a score of 14. Our analysis is based on comparing Sangamo Therapeutics, Inc. with the following peers – Alnylam Pharmaceuticals, Inc, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., Dow Chemical Company, BioMarin Pharmaceutical Inc., Johnson & Johnson, PDL BioPharma, Inc., Biogen Inc. ... Read more (Read more...)